Analysis of Drugs Manual
This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 29, 2021 to September 28, 2023 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only, and inclusion does not imply endorsement by the Drug Enforcement Administration.